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Abstract We have reported that MAP kinase and its activator 
were activated by increase in extracellular osmolarity in Madin- 
Darby canine kidney (MDCK) cells ]J. Clin. Invest. 93 (1994) 
2387-2392]. The activation of MAP kinase quickly disappeared 
when cells in hypertonicity were shifted to isotonicity. Present 
study was planned to elucidate the mechanism for the inactivation 
of MAP kinase when osmolarity decreased. Combination of two 
different phosphatase inhibitors, 10 -6 M okadaic acid and 0.2 
mM sodium orthovanadate, blocked the inactivation of MAP 
kinase after the decrease in osmolarity. We also demonstrated 
that phosphatase toward MAP kinase was activated in response 
to the decrease in osmolarity. These results suggest hat MAP 
kinase is inactivated by phosphatase that is activated when osmo- 
larity decreased. 
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I. Introduction 
The renal medulla is the only tissue that physiologically un- 
dergoes large changes of osmolarity. These changes are part of 
the renal mechanism for producing a concentrated urine. Renal 
medullary cells adapt o an increase in extracellular osmolarity 
by accumulating organic osmolytes. Kidney-derived culture 
cells such as Madin-Darby canine kidney (MDCK) cells accu- 
mulate osmolytes by increasing in transcription of genes for 
osmolyte transporters and synthetases when they are subjected 
to hypertonic stress in vitro (for review, see [1,2]). Hypertonicity 
also increases the levels of mRNA encoding the early gene 
transcription factors, Egr-1 and c-fos in MDCK cells [3]. Mes- 
senger RNAs for Na/K-ATPase and HSP70 are induced by 
hypertonic stress in renal culture cells [3,4]. These studies indi- 
cate that the change of extracellular osmolarity results in the 
generation of signals that transverse the cytoplasm and eventu- 
ally reaches the nucleus. But the mechanism by which extracel- 
lular osmolarity regulates transcription of these genes remains 
to be determined. 
As well as in the signal transduction of growth factors or 
cytokines, recent studies have revealed that MAP kinase family 
functions in the signaling cascade of osmolarity (for review, see 
[5,6]). In yeast, HOG1, a new member of MAP kinase family, 
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Fig. 1 was reported in: J. Clin. Invest. 93 (1994) 2387-2392. 
is essential to grow normally in hypertonic medium and regu- 
late the accumulation f glycerol that is an osmolyte for yeast 
[7]. We have demonstrated for the first time that extracellular 
signal-regulated kinase (ERK), a classical type of MAP kinase, 
and its activator are activated in response to hypertonic stress 
in mammalian cells [8]. A mammalian homologue of HOG1 has 
been cloned as p38 kinase [9]. It has been also reported that a 
distinct MAP kinase, JNK/SAPK, which is originally identified 
as c-jun kinase, is activated by hypertonic stress in mammalian 
cells [10-12]. Both p38 kinase and JNK/SAPK, but not ERK, 
partially rescue yeast mutant lacking in HOG1 activity, suggest- 
ing p38 kinase and JNK/SAPK play a physiological role in the 
osmosensing pathway [9,12]. Furthermore, we have recently 
found that ERK is not essential for transcriptional stimulation 
of osmolyte transporter genes [13]. In result, the role of ERK 
is still unknown in the osmosensing pathway, 
In our previous paper, we showed that ERK induced by 
hypertonic stress was quickly inactivated when MDCK cells in 
hypertonic medium were shifted to isotonic medium [8]. This 
suggested that the decrease in the extracellular osmolarity acti- 
vated an inactivator for ERK. Phosphatase toward ERK (ERK 
phosphatase) may be a most probable candidate as an inactiva- 
tor because ERK is activated by phosphorylation a d is inac- 
tivated by dephosphorylation. To clarify this issue, we tried to 
determine whether ERK phosphatase was regulated by the ex- 
tracellular osmolarity. 
2. Materials and methods 
2.1. Materials 
MDCK cells were a generous gift from the Japanese Cancer Research 
Resources Bank. A recombinant MAP kinase, rat ERK2 fusioned with 
glutathione S-transferase (GST-ERK2) was prepared as described pre- 
viously [8]. Protein phosphatase inhibitors, okadaic acid and sodium 
orthovanadate, were purchased from Wako Pure Chemical Industries 
Ltd. (Osaka, Japan). Other chemicals were from commercial sources. 
2.2. Cell culture 
MDCK cells were cultured and grown as described previously [8]. 
After preincubation with buffer A (10 mM N-2-hydroxyeth- 
ylpiperazine-N'-2-ethane-sulfoni c acid(HEPES).NaOH, pH 7.4/130 
mM NaC1/5.4 mM KC1/1.2 mM CaC1J1.2 mM MgSO4/0.1% dialyzed 
bovine serum albumin), MDCK cells were incubated with hypertonic 
buffer A that was made 500 mOsmol/kg HzO by adding raffinose. In 
order to shift hypertonic cells to isotonic ondition, hypertonic buffer 
A was changed to prewarmed isotonic buffer A 30 min after exposure 
to hypertonic stress. 
2.3. Assay of MAP kinase (ERK) activity 
Activity of ERK was measured as described previously with a slight 
modification [8]. Briefly, cells were directly lysed on culture dishes with 
Laemli's ampling buffer, and then boiled at 100°C for 5 min. Kinase 
activity in these samples were assayed by the in-gel kinase assay method 
using myelin basic protein as a substrate. 
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2.4. Preparation of cytosoljraction 
Except for 32P-labeling of GST-ERK2, the cytosol fraction was pre- 
pared as described previously with slight modifications. Briefly, cells 
were scraped off with 500/11/10 cm dish of ice-cold homogenizing buffer 
(25 mM HEPES.NaOH, pH 7.4/5 mM EDTA/1 mM EGTA/2 mM 
dithiothreitol (DTT)/10 /IM p-amidinophenyl methansulphonyl- 
fluoride/aprotinin (100 klU/ml)). Homogenized in microtubes by 
brief sonication, the homogenate was centrifuged at125,000 × g at 4 ° C 
for 30 min. The supernatant was collected as the cytosol fraction and 
stored at -80°C until use. 
2.5. Preparation of 32p-labeled GST-ERK2 
An active form of crude MAP kinase-kinase was prepared from cells 
exposed to hypertonic stress for 10 rain as described previously, which 
was able to phosphorylate and activate GST-ERK2 [8]. The phospho- 
rylation of GST-ERK2 was performed as described previously with a 
slight modification [8]. Briefly, 50/zg of crude MAP kinase-kinase was 
incubated with 140/ag of GST-ERK2 in 500/A of reaction mixture (20 
mM Tris-HCl, pH 8.0/2 mM EGTA/10 mM MgCIg/100/tM [?'3~P]ATP 
(25/zCi/ml)) at 30°C for 30 min. After diluted with 10 volumes of 
ice-cold stopping buffer (20 mM Tris-HC1, pH 8.0/2 mM EGTA/10 mM 
MgCI~0.1 mM sodium orthovanadate), it was applied on a 8 × 40 mm 
column of glutathione Sepharose CL-4B (Pharmacia LKB). The col- 
umn was extensively washed with 50 mM Tris-HCl, pH 8.0, 32p-labeled 
GST-ERK2 was eluted with 2.5 ml of elution buffer (50 mM Tris-HCl, 
pH 8.0/2 mM reduced glutathione) and stored at -80°C until use. It 
was confirmed by sodium dodecylsulfate-polyacrylamide gel electro- 
phoresis (SDS-PAGE), followed by Coomassie brilliant blue protein 
staining and autoradiography, that GST-ERK2 was exclusively 
phosphorylated. Under this condition, 0.7 pmol of 32P was incorporated 
per mol of GST-ERK2. 
2.6. Assay of ERK phosphatase 
Activity of ERK phosphatase was measured as described previously 
with slight modifications [14]. Briefly, 5 gtl aliquot of the cytosol frac- 
tion was incubated with 400 nM of 32P-labeled GST-ERK2 at 25°C in 
50 /zl of reaction mixture (25 mM HEPES.NaOH, pH 7.4/5 mM 
EDTA/10 mM DTT) in the presence or absence of okadaic acid (10 -6 
M) and sodium orthovanadate (0.2 mM). Twenty minutes later, 750/11 
of charcoal mixture (0.9 M HCI/90 mM sodium pyrophosphate/2 mM 
NaH2POf18%(v/v) activated charcoal) was added and transferred on 
ice. After the centrifugation at 7000 × g for 2 min, the aliquot of the 
supernatant was transferred into a new microtube and 32p released from 
labeled GST-ERK2 was measured by Cerenkov method. Using this 
protocol, 15% of the totoa132p was released maximally from 32p-labeled 
GST-ERK2, where the enzyme activity was almost linear with time. 
3. Results and discussion 
Fig. 1 showed the time course of the activity of ERK in 
MDCK cells after medium osmolarity increased from isotonic 
(300 mOsmol/kg) to hypertonic (500 mOsmol/kg) at Time O. 
Thirty minutes after exposure to hypertonic stress, some cells 
were switched back to isotonic buffer. As shown in Fig. 1, ERK 
was quickly inactivated and returned to near basal level in 60 
rain. On the contrary, kinase activity was maintained under 
persistent hypertonic ondition. When the cells were re-exposed 
to hypertonic stress at Time 90, ERK was activated again. Thus, 
ERK is activated by the change in extracellular osmolarity. 
These results were consistent with our previous reports [8]. It 
is unlikely that degradation of ERK or permanent cell damage 
is involved in this drastic inactivation because ERK was acti- 
vated again at Time 90. 
To see if dephosphorylation of ERK was involved in the 
inactivation of ERKby  decrease in osmolarity, we examined the 
effects of inhibitors for serine/threonine and tyrosine 
phosphatases. After cells were exposed to hypertonic stress for 
30 min, hypertonic buffer A was switched back to isotonic 
buffer A supplemented with 10 -6 M okadaic acid and/or 
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Fig. 1. Time course of ERK activity. Time 0 = cells in isotonic buffer 
A were exposed to hypertonic buffer A (0); Time 30 = some dishes of 
bypertonic ells were switched back to isotonic buffer (e); Time 
90 = some dishes of isotonic cells were shifted to hypertonic buffer 
again (:). After the time indicated, cells were lysed and ERK activity 
was measured. Activity was expressed as 32p incorporated into myelin 
basic protein (MBP) located at 49 kDa. The result was a representative 
time course of three independent experiments. 
0.2 mM sodium orthovanadate. As shown in Fig. 2, neither of 
these inhibitors affected the inactivation of ERK after the de- 
crease in extracellular osmolarity. However, when both of them 
were present, ERK was not inactivated but activated over the 
control level. We speculate that more than two kinds of 
phosphatases might be simultaneously activated because two 
different ypes of inhibitors were necessary to prevent he inac- 
tivation. Alternatively, an unknown type of phosphatase that 
was inhibited only in the presence of okadaic acid plus sodium 
orthovanadate might be activated. The overshooting of ERK 
in the presence of both inhibitors may come from reactivation 
of ERK kinase (MAP kinase-kinase) because ERK kinase is 
also regulated by its own phosphorylation (Fig. 2). 
To determine whether ERK phosphatase is really activated 
by decrease in osmolarity, we directly measured the activity of 
ERK phosphatase. The cytosol fraction prepared after the de- 
crease in extracellular tonicity was incubated with 32p-labeled 
GST-ERK2, and the amount of released 32p was measured. 
Release of 32p was not due to degradation of GST-ERK2, 
because protein band of GST-ERK2 showed no remarkable 
change on SDS-PAGE even after 60 min incubation with the 
cytosol fraction (data not shown). This is the reason why 32p 
released from labeled GST-ERK2 could be designated as the 
activity of ERK phosphatase. As shown in Fig. 3, ERK phos- 
phatase was activated in response to the decrease in osmolarity. 
This activity in the cytosol fraction was partially suppressed by 
the addition of phosphatase inhibitors, which was expected 
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from the result shown in Fig. 2 (Fig. 3). We have shown that 
the activation of MAP kinase-kinase under hypertonicity was 
transient [8]. These and previous results suggested that the 
activation of ERK by hypertonicity is predominantly caused by 
the activation of MAP kinase-kinase, whereas the inactivation 
by the decrease in osmolarity is mainly due to the activation of 
ERK phosphatase. Thus, ERK could be a signal transducer of 
extracellular osmolarity, although its role in the osmosensing 
pathway remains unclear. 
A candidate for an osmosensor located on plasma mem- 
brane, SLN1, has been reported in Saccharomyces cerevisiae 
[15,16]. Several phosphatases were identified as multicopy sup- 
pressor genes using yeast mutants of SLN1 [17]. These reports 
suggest hat phosphatases are involved in the signal transduc- 
tion of extracellular osmolarity. It has been demonstrated that 
phosphatases toward threonine/tyrosine residues function as 
MAP kinase inactivator in the signaling pathway of growth 
factors and stress response [18-25]. Although our assay system 
is likely to contain several phosphatases toward each step of 
MAP kinase cascade, our results strongly suggest hat phos- 
phatase toward ERK is regulated by the extracellular osmolar- 
ity. Further examination are necessary to clarify the role of 
ERK and ERK phosphatase in the osmosensing pathway. 
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Fig. 2. The effects of okadaic acid and sodium orthovanadate on MAP 
kinase activity. Cells incubated with hypertonic buffer A for 30 rain was 
switched back to isotonic buffer A supplemented with okadaic acid 
(OA; final, 10 -6 M) and/or sodium orthovanadate (V; final, 0.2 mM). 
Ten minutes later, cells were lysed and ERK activity was measured. The 
activity 10 min after incubation with hypertonic buffer A was desig- 
nated as 100% (Control). The results were expressed as means + S.E.M. 
(n = 3). Data were compared by analysis of variance. *P < 0.05 vs. in 
the absence of phosphatase inhibitors. 
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Fig. 3. Activity of ERK phosphatase. Time 0 -- cells in isotonic buffer 
A were exposed to hypertonic buffer A. Time 30 = some dishes of 
hypertonic ells were switched back to isotonic buffer. The cytosol 
fraction was prepared at the time indicated, and the activity of ERK 
phosphatase was measured. (o); cells under hypertonicity in the absence 
of phosphatase inhibitors, (e); cells under hypertonicity followed by 
isotonicity in the absence of phosphatase inhibitors, (v); cells under 
hypertonicity in the presence of phosphatase inhibitors, (v); ceils under 
hypertonicity followed by isotonicity in the presence of phosphatase 
inhibitors. The activity at Time 0 was designated as 100%, where 
5.0 + 0.9% (©) and 3.7 _+ 0.6% (v) of the total 32p were released 
from the substrate, respectively. The results were expressed as 
means + S.E.M. (n = 4). Data were compared by analysis of variance. 
*P < 0.05 vs. Time O. 
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